Lanean...
DEMETHYLATING AGENTS IN MYELOID MALIGNANCIES
PURPOSE OF REVIEW: Two demethylating agents are approved in myelodysplastic syndromes (MDS): 5-azacitidine and 5-aza-2′-deoxycitidine (decitabine). These drugs are structurally related and induce DNA hypomethylation. Aberrant DNA methylation is associated with gene silencing. It is proposed that hyp...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2008
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3873866/ https://ncbi.nlm.nih.gov/pubmed/18841054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e328313699c |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|